We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Digital Test Directly Measures HIV Viral Load in Single Drop of Blood

By LabMedica International staff writers
Posted on 22 Jun 2023
Print article
Image: In the new quantification method, a molecular signal shines green when HIV is detected in an RNA molecule (Photo courtesy of Penn State)
Image: In the new quantification method, a molecular signal shines green when HIV is detected in an RNA molecule (Photo courtesy of Penn State)

One milliliter of blood consists of approximately 15 individual drops. For a person living with human immunodeficiency virus (HIV), each of these drops could house anywhere from less than 20 to over 500,000 viral copies. This measure, known as the viral load, is essential for clinicians to evaluate the response to anti-viral drugs and monitor potential disease progression. However, viral load testing, which must be repeated several times during treatment, can be time-consuming. Researchers have now designed a digital assay that can effectively measure HIV presence in a single blood drop, offering a more time and cost-efficient solution. This assay lays the groundwork for diagnostic tools for a wide range of infectious diseases.

Traditional HIV viral load tests require genetic material extraction from the sample, which is then amplified and compared to reference samples. The gold standard RT-PCR test can approximate the actual viral load, but it doesn't measure it directly. Researchers at Penn State (University Park, PA, USA) devised a more direct method with their Self-digitization Through Automated Membrane-based Partitioning (STAMP) test, which is less expensive, quicker, and requires less blood than the RT-PCR. The method allows the researchers to extract viral RNA (the virus's genetic material) from a small blood sample and mix it with a unique protein called Cas13, part of the CRISPR system. CRISPR-Cas13 is renowned for enabling RNA sequence targeting and manipulation. The researchers use it not just for its editing abilities, but also for its diagnostic potential. The researchers are employing CRISPR-Cas13 to detect and signal the presence of HIV.

After the RNA is combined with Cas13, the researchers place a nanopore polycarbonate membrane - a readily available, cost-effective material - on the mixture. The nanopores are so minute that they can separate the mixture into single droplets, each containing only one RNA molecule linked to the Cas13 protein. If HIV is present in the RNA molecule, the Cas13 protein - which HIV RNA activates - will cut reporting molecules, creating a detectable signal. The number of droplets indicating this signal helps researchers determine the HIV quantity in the blood. More signal-bearing droplets mean a higher viral load. The team tested this method using synthetic HIV RNA to optimize sensitivity and accuracy before testing lab plasma and eventually patient plasma samples. The STAMP method was validated by measuring HIV viral loads in 20 patient plasma samples, showing comparable accuracy to the traditional RT-PCR method, which generally requires more blood.

The researchers are in the process of securing more samples for further testing. They also found that their approach could accurately assess HIV viral loads at or above approximately 2,000 virus copies per milliliter of blood. Viral loads below 10,000 copies per milliliter are considered low; those at 20 copies or fewer are undetectable; and high viral loads are around 100,000 copies, potentially extending beyond a million. According to the team, the detection range of 2,000 to 10,000 can be crucial for clinicians monitoring patients for viral rebound. Individuals undergoing antiretroviral therapy (ART) can reach undetectable virus levels, making them non-infectious sexually, but an increase in virus levels could suggest ART resistance development or other issues.

“While further improvements are needed to enhance its detection limit and automate the setup, the STAMP-based digital CRISPR method shows great potential for advancing HIV viral load monitoring,” said corresponding author Weihua Guan, stating that the researchers will continue to enhance the platform’s efficiency and accuracy to quantify multiple viruses, with the ultimate goal of bringing the device to market.

Related Links:
Penn State 

Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Collection Container
Urine Monovette
New
Laboratory Electric Thermostat
DNP-9025A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.